On Jan. 2, Hookipa inked a non-binding agreement that would have created a merged company with Poolbeg via an all-stock ...
In a turbulent market environment, Vincerx Pharma, Inc. (VINC) stock has reached its 52-week low, trading at $1.3. According to InvestingPro analysis, the company maintains a healthy current ratio of ...
This significant downturn reflects a broader trend for the... Vincerx Pharma, Inc. (NASDAQ:VINC), a pharmaceutical company, announced today an agreement with H.C. Wainwright & Co., LLC to sell up to ...
Investing.com - Vincerx Pharma reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that was inline with expectations. Vincerx Pharma announced ...
Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products.
As per data from GlobalData’s Pharmaceutical Intelligence Centre, the highest number of deals made in radiopharmaceuticals space for the past decade took place in 2024. Pio argues that this trend is ...
The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.
Both facilities specialise in viral vector development and manufacturing. A Thermo Fisher spokesperson told Pharmaceutical Technology: “In light of recent shifts in customer timelines and utilisation ...